Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
High-dose semaglutide and tirzepatide have produced even greater results in non-diabetic populations, often achieving a 10-15% reduction in baseline body weight
Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption
Adding 2 mL to a 10mg vial gives 5 mg/mL
If youre starting semaglutide treatment and want guidance on which formulation is right for your situation, the intake assessment at TrimRx connects you with a provider who can match treatment details, including formulation considerations, to your individual health profile
US$ 27.79
US$ 29.78
US$ 21.73
US$ 24.70
US$ 23.11
US$ 23.47
US$ 20.17
